4 products were found matching "Cay10005707-%25"!
No results were found for the filter!
alpha-CEHC
Item number: Cay10007705-25
Molecules having vitamin E antioxidant activity include four tocopherols (alpha, beta, delta, and gamma) and four tocotrienols (alpha, beta, delta, and gamma). alpha-Tocopherol is the major lipid soluble antioxidant in vivo and protects against lipid peroxidation. alpha-CEHC is the major urinary metabolite of...
| Keywords: | 3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-propanoic acid |
| Application: | Bioactive lipid assays |
| CAS | 4072-32-6 |
| MW: | 278.3 D |
From 38.00€
*
AS-605240
Item number: Cay10007707-25
Phosphatidylinositol 3-kinase (PI3K) catalyzes the phosphorylation of phosphatidylinositol at the three position to produce the second messengers PtdIns-(3,4)-P2 and PtdIns-(3,4,5)-P3. PI3Kgamma is a class 1B PI3K that is composed of a p110 catalytic subunit and a p101 or p84 regulatory subunit, whereas PI3Kalpha,...
| Keywords: | 5-(6-quinoxalinylmethylene)-2,4-thiazolidinedione |
| Application: | PI3K inhibitor |
| CAS | 648450-29-7 |
| MW: | 257.3 D |
From 43.00€
*
(2S)-OMPT
Item number: Cay10005707-5
Lysophosphatidic acid (LPA) is a potent lipid mediator that elicits its effect through four distinct receptors - LPA1/EDG-2, LPA2/EDG-4, LPA3/EDG-7 and LPA4/GPR23. OMPT is a selective agonist of the lysophosphatidic acid 3 (LPA3) receptor. It exhibits EC50 values of 68 nM and >6.8 µM for calcium mobilization in LPA1...
| Keywords: | 9Z-octadecenoic acid, (2S)-3-[(hydroxymercaptophosphinyl)oxy]-2-methoxypropyl ester, triethyl ammonium salt (1:2) |
| Application: | LPA3 receptor agonist |
| CAS | 1217471-69-6 |
| MW: | 669 D |
From 96.00€
*
Lurasidone
Item number: Cay9000570-25
Lurasidone is an atypical antipsychotic that binds to dopamine D2, serotonin (5-HT) receptor subtypes 5-HT2A, 5-HT1A, and 5-HT7, and alpha2C-adrenergic receptors (Kis = 1.68, 2.03, 6.75, 0.495, and 10.8 nM, respectively). In vivo, pre-training administration of lurasidone (1 and 3 mg/kg) reverses impairment in...
| Keywords: | (3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1... |
| Application: | HTR1A / HTR2 / HTR7 / DRD2 modulator |
| CAS | 367514-87-2 |
| MW: | 492.7 D |
From 77.00€
*
